naratriptan has been researched along with Disease Models, Animal in 6 studies
naratriptan: structure given in first source
Disease Models, Animal: Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Trigeminal autonomic cephalalgias are highly disabling primary headache disorders, characterized by severe unilateral head pain and associated ipsilateral cranial autonomic features." | 1.38 | A translational in vivo model of trigeminal autonomic cephalalgias: therapeutic characterization. ( Akerman, S; Goadsby, PJ; Holland, PR; Lasalandra, MP; Summ, O, 2012) |
| "Naratriptan has high affinity for human recombinant 5HT1B and 5HT1D receptors (pKi = 8." | 1.30 | Naratriptan: biological profile in animal models relevant to migraine. ( Beattie, DT; Connor, HE; Feniuk, W; Humphrey, PP; North, PC; Oxford, AW; Saynor, DA, 1997) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (33.33) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Abrams, RPM | 1 |
| Yasgar, A | 1 |
| Teramoto, T | 1 |
| Lee, MH | 1 |
| Dorjsuren, D | 1 |
| Eastman, RT | 1 |
| Malik, N | 1 |
| Zakharov, AV | 1 |
| Li, W | 1 |
| Bachani, M | 1 |
| Brimacombe, K | 1 |
| Steiner, JP | 1 |
| Hall, MD | 1 |
| Balasubramanian, A | 1 |
| Jadhav, A | 1 |
| Padmanabhan, R | 1 |
| Simeonov, A | 1 |
| Nath, A | 1 |
| Robert, C | 1 |
| Bourgeais, L | 1 |
| Arreto, CD | 1 |
| Condes-Lara, M | 1 |
| Noseda, R | 1 |
| Jay, T | 1 |
| Villanueva, L | 1 |
| Akerman, S | 1 |
| Holland, PR | 1 |
| Summ, O | 1 |
| Lasalandra, MP | 1 |
| Goadsby, PJ | 1 |
| Tsaltas, E | 1 |
| Kontis, D | 1 |
| Chrysikakou, S | 1 |
| Giannou, H | 1 |
| Biba, A | 1 |
| Pallidi, S | 1 |
| Christodoulou, A | 1 |
| Maillis, A | 1 |
| Rabavilas, A | 1 |
| Connor, HE | 1 |
| Feniuk, W | 1 |
| Beattie, DT | 1 |
| North, PC | 1 |
| Oxford, AW | 1 |
| Saynor, DA | 1 |
| Humphrey, PP | 1 |
| Johnson, KW | 1 |
| Schaus, JM | 1 |
| Durkin, MM | 1 |
| Audia, JE | 1 |
| Kaldor, SW | 1 |
| Flaugh, ME | 1 |
| Adham, N | 1 |
| Zgombick, JM | 1 |
| Cohen, ML | 1 |
| Branchek, TA | 1 |
| Phebus, LA | 1 |
6 other studies available for naratriptan and Disease Models, Animal
| Article | Year |
|---|---|
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
Topics: Animals; Antiviral Agents; Artificial Intelligence; Chlorocebus aethiops; Disease Models, Animal; Dr | 2020 |
Paraventricular hypothalamic regulation of trigeminovascular mechanisms involved in headaches.
Topics: Action Potentials; Animals; Biotin; Corticosterone; Dextrans; Disease Models, Animal; GABA Antagonis | 2013 |
A translational in vivo model of trigeminal autonomic cephalalgias: therapeutic characterization.
Topics: Action Potentials; Analysis of Variance; Animals; Disease Models, Animal; Electric Stimulation; Elec | 2012 |
Reinforced spatial alternation as an animal model of obsessive-compulsive disorder (OCD): investigation of 5-HT2C and 5-HT1D receptor involvement in OCD pathophysiology.
Topics: Animals; Anti-Anxiety Agents; Antidepressive Agents, Tricyclic; Desipramine; Diazepam; Disease Model | 2005 |
Naratriptan: biological profile in animal models relevant to migraine.
Topics: Animals; Basilar Artery; Cerebrovascular Circulation; Disease Models, Animal; Dogs; Dose-Response Re | 1997 |
5-HT1F receptor agonists inhibit neurogenic dural inflammation in guinea pigs.
Topics: Animals; Benzamides; Carbazoles; Disease Models, Animal; Guinea Pigs; In Situ Hybridization; Indoles | 1997 |